Want to see BKYI full AI Analyst Report?
BKYI Stock Chart & Stats
$0.88
-$0.29(-17.16%)
At close: 4:00 PM EST
$0.88
-$0.29(-17.16%)
Day’s Range― - ―
52-Week Range$3.10 - $19.70
Previous CloseN/A
Volume225.68K
Average Volume (3M)10.59K
Market Cap
$4.99M
Enterprise Value$3.95
Total Cash (Recent Filing)$2.25M
Total Debt (Recent Filing)$42.41K
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Aug 17, 2026EPS Estimate
-0.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.31
Shares Outstanding1,085,360
10 Day Avg. Volume23,560
30 Day Avg. Volume10,591
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.47
Price to Sales (P/S)0.59
P/FCF Ratio-0.77
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.3
Revenue Forecast (FY)$9.00M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement continues to expect sequential revenue growth and improved profitability in 2025.
Product InnovationBKYI recently entered the passkey authentication market with the launch of 'Passkey:YOU', a unique password-less authentication solution.
Sales StrategyBKYI is building a military- and intelligence-focused global sales team targeting the growing EU defense opportunity.
Bears Say
Brand Strategy ShiftResults were below expectations due to an intentional shift away from its Swivel Secure brand to focus on core Bio-Key branded solutions.
BIO-key International News
BKYI FAQ
What was Bio-Key International’s price range in the past 12 months?
Bio-Key International lowest stock price was $3.10 and its highest was $19.70 in the past 12 months.
What is Bio-Key International’s market cap?
Bio-Key International’s market cap is $4.99M.
When is Bio-Key International’s upcoming earnings report date?
Bio-Key International’s upcoming earnings report date is Aug 17, 2026 which is in 29 days.
How were Bio-Key International’s earnings last quarter?
Currently, no data Available
Is Bio-Key International overvalued?
According to Wall Street analysts Bio-Key International’s price is currently Overvalued.
Does Bio-Key International pay dividends?
Bio-Key International does not currently pay dividends.
What is Bio-Key International’s EPS estimate?
Bio-Key International’s EPS estimate is -0.8.
How many shares outstanding does Bio-Key International have?
Bio-Key International has 1,085,360 shares outstanding.
What happened to Bio-Key International’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bio-Key International?
Currently, no hedge funds are holding shares in BKYI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bio-Key International
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Technical Analysis
Ownership Overview
10.91% Insiders
4.62% Mutual Funds
― Other Institutional Investors
84.47% Public Companies and
Individual Investors